Direkt zum Inhalt

Owner only: item control page
Meindl, Christine ; Hochadel, Matthias ; Frankenstein, Lutz ; Bruder, Oliver ; Pauschinger, Matthias ; Hambrecht, Rainer ; von Scheidt, Wolfgang ; Pfister, Otmar ; Hartmann, Andreas ; Maier, Lars S. ; Senges, Jochen ; Unsöld, Bernhard

The role of diabetes in cardiomyopathies of different etiologies—Characteristics and 1-year follow-up results of the EVITA-HF registry

Meindl, Christine , Hochadel, Matthias, Frankenstein, Lutz, Bruder, Oliver, Pauschinger, Matthias, Hambrecht, Rainer, von Scheidt, Wolfgang, Pfister, Otmar, Hartmann, Andreas, Maier, Lars S., Senges, Jochen and Unsöld, Bernhard (2020) The role of diabetes in cardiomyopathies of different etiologies—Characteristics and 1-year follow-up results of the EVITA-HF registry. PLOS ONE 15 (6), e0234260.

Date of publication of this fulltext: 17 Dec 2020 14:27
Article
DOI to cite this document: 10.5283/epub.44152


Abstract

Background Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). Methods EVIdence ...

Background Type 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardiomyopathy. In contrast to diabetes and IHD, limited data exist regarding patients with diabetes and dilated cardiomyopathy (DCM). Methods EVIdence based TreAtment in Heart Failure (EVITA-HF) comprises web-based case report data on demography, diagnostic measures, adverse events and 1-year follow-up of patients hospitalized for chronic heart failure and an ejection fraction <= 40%. In the present study we focused on the results of patients with diabetes and heart failure. Results Between February 2009 and November 2015, 4101 patients with chronic heart failure were included in 16 tertiary care centers in Germany. The mortality in patients with diabetes and DCM (n = 323) was more than double (15.2%) than that of DCM patients without diabetes (6.5%, p<0.001, n = 885). In contrast the mortality rate of patients withIHDwas not influenced by the presence of diabetes (17.6% in patients withIHDand diabetes n = 945, vs. 14.7% in patients withIHDand no diabetes, n = 1236, p = 0.061). The results also remained stable after performing a multivariable analysis (unadjusted p-value for interaction = 0.002, adjusted p = 0.046). Conclusion The influence of diabetes on the mortality rate is only significant in patients with DCM not in patients with CAD. Therefore, the underlying mechanisms of this effect should be studied in greater detail to improve patient care and outcome.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitlePLOS ONE
Publisher:PLOS
Open Access Type:Gold (with APC)
Place of Publication:SAN FRANCISCO
Volume:15
Number of Issue or Book Chapter:6
Page Range:e0234260
Date11 June 2020
InstitutionsMedicine > Lehrstuhl für Innere Medizin II
Identification Number
ValueType
10.1371/journal.pone.0234260DOI
KeywordsHEART-FAILURE PATIENTS; VENTRICULAR DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; EJECTION FRACTION; MELLITUS; OUTCOMES; DISEASE; EMPAGLIFLOZIN; ABNORMALITIES; LISINOPRIL;
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-441523
Item ID44152

Export bibliographical data

Owner only: item control page

nach oben